Aby Buchbinder, VP, Clinical Development at ENZON PHARMACEUTICALS INC (ENZN), sold 2,700 shares at $7.06 ($19K) on 2011-11-08, disclosed to the SEC on 2011-11-10.
Open-market sale of $19k ENZN by VP, Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.